Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Real Time & Level II Data
Showcase Companies
DealRoom
News Focus
Private Placement: Ready for a Golden Opportunity in Ghana and Canada? (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Abbvie Inc
ABBV
Alternate Symbol(s):
N.ABBV
Healthcare
Biotechnology
AbbVie Inc. (AbbVie) is a diversified research-based biopharmaceutical company. The Company is engaged in the research and development, manufacturing, commercialization and sale of medicines and therapies. It offers products in various therapeutic categories, including immunology products, which include Humira, Skyrizi and Rinvoq; oncology products, which include Imbruvica and Venclexta...
/Venclyxto; aesthetics products that include Botox Cosmetic, The Juvederm Collection of Fillers and others; neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; eye care products, which consists of Lumigan/Ganfort, Alphagan/Combigan and Restasis, and other key products, which include Mavyret/Maviret, Creon, Lupron, Linzess/Constella and Synthroid. Its products are sold to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from the AbbVie-owned distribution centers and public warehouses.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NYSE:ABBV)
New Post
View:
Posts & Comments
Threaded Posts
(11)
•••
Wrywisdom
X
Post by
Wrywisdom
on Aug 10, 2022 3:21pm
Incredible Value. ENTG at about 25% of One Years Revenue
.with revenues now demonstrating an upward Trajectory amd likely attaining profitability within a couple of quarters. May reportage for example indicates record first quarter 2022 results:
...more
(4)
•••
zeropointenergy
X
Post by
zeropointenergy
on Oct 06, 2021 7:20am
ONE DRUG PILL WIPES OUT COVID 19!
India's Ivermectin Blackout - Part V: The Secret Revealed ... Sep 27, 2021 · By September 12, 2021, Livemint reported that 34 districts were declared COVID-free
...more
Datametrex AI Launches AnalyticsGPT
posted Sep 24, 2023 9:00am by
Datametrex AI Ltd
-
|
The underlying AnalyticsGPT technology was developed in conjunction with and used by the U.S. and Canadian Military for defense initiatives and is characterized by its robustness, reliability, and precision. In the following weeks, Datametrex will be announcing additional packages and pricing models designed to allow smaller businesses to leverage the power of ...read more
(33)
•••
plomar2011
X
Post by
plomar2011
on Sep 01, 2021 1:58pm
what was the big drop ?? saw no news
what was the big drop ?? saw no news
(1)
•••
edwardebreen15
X
Post by
edwardebreen15
on Aug 02, 2021 8:42am
Multiple Sclerosis Therapies Market Industry Growth 2026
According to IMARC Group’s latest report, titled “Multiple Sclerosis Therapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, The global multiple sclerosis
...more
(495)
•••
Mil_Man54
X
Post by
Mil_Man54
on Dec 26, 2020 8:13am
Bonvoyage12....Lying Pumper
Ignore this clown as he posts lies trying to mislead investors about the actual state of the company...he also posts this same BS on multiple boards
(0)
•••
MagnetSauce
X
Post by
MagnetSauce
on Sep 18, 2020 10:46am
🥇💊$HUGE FSD PHARMA COVID19 FDA PHASE 2A🥇💊
Good progress takes time don't be fooled by short sellers
...more
(33)
•••
Nonyah
X
Post by
Nonyah
on Aug 09, 2020 10:42am
Dev Tools
Better Development Tools for a New Golden Era of Psychopharmacology https://www.thecannabisinvestor.ca/better-development-tools-for-a-new-golden-era-of-psychopharmacology/
(3)
•••
KingTiger
X
Post by
KingTiger
on Jun 26, 2019 2:27pm
khiron will be the canopy growth of south america
Earnings estimates Currently growing building the company but here are the growth estimates :) FY19 -.42 FY20 -.22
...more
Thematica Insights Report and Investor Guide
Thematica: Battery Metals Report
Download our Investor’s Guide and learn how/why Battery Metals are playing a vital role in the EV Revolution.
Jeff Nielson
22 September 2023 09:28
(2)
•••
Raw_Blitz
X
Post by
Raw_Blitz
on Oct 03, 2018 2:47pm
My Technical Analysis for ABBVIE !
Feel free to leave a message with some opinion! https://www.tradingview.com/chart/ABBV/sDz8wSFY-ABBVIE-Technical-Analysis/
(0)
•••
Rambo007
X
Post by
Rambo007
on Aug 26, 2018 12:48pm
good video who Diego might pick
https://www.stockhouse.com/companies/bullboard?symbol=c.thc&postid=28517119
Thank You
Your Report has been submitted.
Report Abusive Content
×
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}}
{{story.headline}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Nickel Miner Announces a Battery Supply Chain MOU with “PPES”, a JV Between Toyota and Panasonic
Electric Dreams: Transforming the World with a Clean Energy Future - Download Free Report Now!
Criminal syndicate allegedly infiltrated Barrick Gold subsidiary